Navigation Links
Replidyne and Cardiovascular Systems Sign Merger Agreement
Date:11/4/2008

m" target="_new">http://www.csi360.com.

Safe Harbor

This press release contains plans, intentions, objectives, estimates and expectations that constitute forward-looking statements about Replidyne and CSI that involve significant risks and uncertainties. Examples of such statements include, but are not limited to, the anticipated closing date of the merger, the expected cash that will be available to CSI at the closing of the merger, the expected ownership of the stockholders of Replidyne and CSI after the closing of the merger, and the anticipated benefits of the transaction. Actual results could differ materially from those discussed in the forward looking statements due to a number of factors including, the outcome of the shareholder vote for the proposed merger, the outcome of Replidyne's efforts to wind up its business including the disposition of its research pipeline programs; regulatory developments in the U.S. and foreign countries; the accuracy of Replidyne's or CSI's estimates regarding expenses, future revenues and capital requirements; and CSI's ability to obtain and maintain intellectual property protection for product candidates. These and additional risks and uncertainties are described more fully in CSI's registration statement on Form 10 filed with the Securities and Exchange Commission (SEC) on October 28, 2008 and Replidyne's most recent Form 10-Q filed with the SEC under the Securities Exchange Act of 1934. Copies of filings made with the SEC are available through the SEC's electronic data gathering analysis and retrieval system (EDGAR) at http://www.sec.gov. All forward-looking statements made in the press release are made as of the date hereof and neither Replidyne nor CSI assumes any obligation to update the forward-looking statements in the document.

Additional information about the Merger and Where to Find It

This communication may be deemed to be solicitation ma
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Replidyne Announces Second Quarter 2008 Results From Operations
2. Replidyne Terminates Faropenem Agreements
3. Replidyne to Report First Quarter 2008 Earnings
4. Replidyne Announces 2007 Fourth Quarter and Full Year Results
5. Replidyne to Report 2007 Fourth Quarter and Year-End Earnings
6. Replidyne to Announce Third Quarter 2007 Earnings
7. Interleukin Genetics to Present New Findings at the 11th Cardiovascular Genomics and Atherosclerosis Symposium
8. Proteon Therapeutics to Present New Data on PRT-201 at Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium in Washington, D.C., October 13, 2008
9. CorMatrix Cardiovascular to Present Data on Its Next Generation ECM Technology(TM) at Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference in Washington, D.C.
10. Core Laboratories Joint Venture Agreement Between genae associates, VIBGYOR Scientific Research, Cardiovascular Center Aalst and J.B. Dahm
11. Physician to Implant the CATANIA(TM) Coronary Stent System With Polyzene(R)-F to Treat Chronic Total Occlusion During Live Case at the Paris Cardiovascular Interventions Course (Francophone) 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Genedata, a leading provider of ... and life science research, today announced AB Enzymes ... its bioinformatics platform for strain genome data management ... AB Enzymes, one of the world’s oldest and ... Genedata Selector accompanied by bioinformatics consulting services. Genedata ...
(Date:5/22/2013)... May 22, 2013 Mold remediation could take ... that there is a way to cut down the process' ... its latest post the details of a method how ... , Mold could be prevented, My Cleaning Products said. But ... stated that a mold remediation must then be promptly implemented ...
(Date:5/22/2013)... 2013 Envera announced today that Michael ... Mr. McErlean has an extensive background in cell production ... his career. , Mike Matheny, President and ... have Mike join our team”. “Mike’s background is perfectly ... fermentation and downstream processing equipment”, added Matheny. “Mike’s ...
(Date:5/22/2013)... 22, 2013  Moderna Therapeutics, the pioneering company developing ... enable the in vivo production of therapeutic ... will join Moderna in early July as its ... a proven leader in the design and implementation of ... discovery to translation, clinical operations and commercial preparedness. John ...
Breaking Biology Technology:AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Envera Appoints Michael McErlean Fermentation Manager 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3
... of Complex Arrhythmias Achieved Approval Considered ... Jan. 15 Stereotaxis, Inc. (Nasdaq:,STXS) announced today ... U.S. Food,and Drug Administration (FDA) has approved its ... ablation in the United States., "The long-awaited ...
... Detail Latest Cardiac Surgery Technology to be Held ... January 26th at 6:30 p.m. Eastern ... technology companies will host the first annual After Hours Event,on ... the yacht,"Princess Lady." The invitation-only event, immediately preceding the,largest meeting ...
... response to the,Federal Drug Administration,s announcement today that ... consumption, Smithfield Foods, Inc.,(NYSE: SFD ) reiterated ... produce meat products from cloned animals. The science ... leaders in our industry,we will continue to monitor ...
Cached Biology Technology:Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter 2Stereotaxis Announces FDA Approval of Its Partnered Magnetic Irrigated Catheter 3Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 2Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 3Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons 4
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
(Date:5/21/2013)... become most deadly when they metastasize and spread tumors ... it becomes very difficult for doctors to locate and ... at the University of Missouri have found a way ... wherever they may be in the body. Michael Lewis, ... of Veterinary Medicine, says being able to target secondary ...
(Date:5/21/2013)... largest scientific society, invites news media coverage of ... 2013, in Indianapolis, Ind. It will take place ... hotels. , With more than 7,100 presentations on ... astronomy to zoology ― the meeting will offer ... of spot news and feature possibilities. The topics ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2
... with genetic risk of bowel cancer has found that ... of insurance implications. "This indicates that people have ... decision to have potentially life saving genetic testing," says ... Melbourne,s Key Centre for Women,s Health in Society. ...
... mayapple may soon offer an alternative to an Asian ... its anti-cancer properties. The near-extinct Asian plant, Podophyllyum ... etoposide, the active ingredient in a drug used for ... is a cousin of the common mayapple weed found ...
... This is the conclusion of a study which has analyzed the ... 14 years. The decrease in this activity and the fall in ... 10%) are the reasons why the "war", in the sense of ... Researchers from the Mediterranean Institute for Advanced Studies (IMEDEA-CSIC) ...
Cached Biology News:Fear of insurance rejection deters potentially life saving genetic tests for bowel cancer 2Anticancer compound found in American mayapple 2The war against wildlife comes to an end in Southern Europe 2
RABBIT ANTI HUMAN CHYMOTRYPSIN...
MSE ANTI CAN. CD3:FITC/RAT ANTI CD4:RPE...
MOUSE ANTI POLY (ADP-RIBOSE) Immunogen: Purified poly (ADP-ribose) polymer, 10-50 unit chain length...
... et.al. (1997) • Contains short ... biochemistry & molecular biology, arranged ... Entries give details of biochemical ... which they are involved and ...
Biology Products: